[go: up one dir, main page]

MA52946A - Composés - Google Patents

Composés

Info

Publication number
MA52946A
MA52946A MA052946A MA52946A MA52946A MA 52946 A MA52946 A MA 52946A MA 052946 A MA052946 A MA 052946A MA 52946 A MA52946 A MA 52946A MA 52946 A MA52946 A MA 52946A
Authority
MA
Morocco
Prior art keywords
compounds
Prior art date
Application number
MA052946A
Other languages
English (en)
Other versions
MA52946B1 (fr
Inventor
Steven Boakes
Pamela Brown
Scott Coleman
Michael Dawson
Esther Duperchy
Roy Lester
Dean Rivers
Mona Simonovic
Original Assignee
Spero Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spero Therapeutics Inc filed Critical Spero Therapeutics Inc
Publication of MA52946A publication Critical patent/MA52946A/fr
Publication of MA52946B1 publication Critical patent/MA52946B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA52946A 2018-06-25 2019-06-25 Composés MA52946B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862689602P 2018-06-25 2018-06-25
PCT/EP2019/066819 WO2020002325A1 (fr) 2018-06-25 2019-06-25 Composés

Publications (2)

Publication Number Publication Date
MA52946A true MA52946A (fr) 2021-04-28
MA52946B1 MA52946B1 (fr) 2024-03-29

Family

ID=67107423

Family Applications (1)

Application Number Title Priority Date Filing Date
MA52946A MA52946B1 (fr) 2018-06-25 2019-06-25 Composés

Country Status (32)

Country Link
US (2) US11459357B2 (fr)
EP (2) EP3810633B1 (fr)
JP (2) JP7488774B2 (fr)
KR (1) KR20210054500A (fr)
CN (2) CN112789287B (fr)
AR (1) AR116663A1 (fr)
AU (2) AU2019294261B2 (fr)
BR (1) BR112020026663A2 (fr)
CA (1) CA3103158A1 (fr)
CO (1) CO2020016080A2 (fr)
DK (1) DK3810633T3 (fr)
EA (1) EA202092819A1 (fr)
ES (1) ES2971732T3 (fr)
FI (1) FI3810633T3 (fr)
HR (1) HRP20240028T1 (fr)
HU (1) HUE065134T2 (fr)
IL (1) IL279620A (fr)
LT (1) LT3810633T (fr)
MA (1) MA52946B1 (fr)
MD (1) MD3810633T2 (fr)
MX (1) MX2020013811A (fr)
NZ (1) NZ771833A (fr)
PH (1) PH12020552240A1 (fr)
PL (1) PL3810633T3 (fr)
PT (1) PT3810633T (fr)
RS (1) RS65128B1 (fr)
SG (1) SG11202012747VA (fr)
SI (1) SI3810633T1 (fr)
TW (1) TWI851584B (fr)
UA (1) UA128162C2 (fr)
WO (1) WO2020002325A1 (fr)
ZA (1) ZA202301937B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2968902C (fr) 2014-11-26 2023-08-29 New Pharma Licence Holdings Limited Composes derives de la polymyxine
FI3810633T3 (fi) * 2018-06-25 2024-02-09 Spero Therapeutics Inc Yhdisteitä
WO2022098950A1 (fr) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Composés
CN115490757A (zh) * 2021-06-18 2022-12-20 华南理工大学 活性氧自由基响应的多粘菌素前药化合物及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
WO1988000950A2 (fr) 1986-08-06 1988-02-11 Fauchere Jean Luc Fabrication de conjugues a liaisons de covalence a partir d'un antibiotique et d'un derive non toxique de la polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (fr) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
MXPA06003573A (es) 2003-09-30 2006-08-31 Kohi Corp Composiciones y metodos para tratar quemaduras.
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
ES2575521T3 (es) 2006-08-11 2016-06-29 Northern Antibiotics Oy Derivados de polimixina y sus usos
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (fr) 2009-05-14 2010-11-18 Monash University Composés antimicrobiens
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (fr) 2010-10-21 2012-04-26 Monash University Composés antimicrobiens
WO2012168820A1 (fr) * 2011-06-08 2012-12-13 Pfizer Inc. Dérivés de polymyxine utiles en tant qu'agents antibactériens
CN103946233A (zh) 2011-11-18 2014-07-23 诺瓦克塔生物系统有限公司 多黏菌素衍生物
HUE059544T2 (hu) 2013-05-22 2022-11-28 Spero Therapeutics Inc Polimixin-származékok és ezek alkalmazása kombinációs terápiában különbözõ antibiotikumokkal
SI3116897T1 (sl) * 2014-03-11 2022-06-30 Spero Therapeutics, Inc. Derivati polimiksina in njihova uporaba v kombinacijskem zdravljenju skupaj z različnimi antibiotiki
WO2015149131A1 (fr) 2014-04-01 2015-10-08 Monash University Dérivés de polymyxine utilisés comme composés antimicrobiens
CA2968902C (fr) 2014-11-26 2023-08-29 New Pharma Licence Holdings Limited Composes derives de la polymyxine
BR112017010888A2 (pt) * 2014-12-17 2018-02-27 Hoffmann La Roche método para produzir um produto de conjugação enzimática de três polipeptídeos
WO2016166103A1 (fr) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Dérivés de polymyxine
WO2017054047A1 (fr) * 2015-09-29 2017-04-06 Monash University Composés antimicrobiens dérivés de polymyxine
EP3471763A4 (fr) * 2016-06-16 2020-04-29 International AIDS Vaccine Initiative, Inc. Compositions pour lutter contre la tuberculose et méthodes de traitement ou de prévention de la tuberculose
FI3810633T3 (fi) * 2018-06-25 2024-02-09 Spero Therapeutics Inc Yhdisteitä
WO2020014501A1 (fr) 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions et procédés pour le traitement d'infections bactériennes

Also Published As

Publication number Publication date
AR116663A1 (es) 2021-06-02
US11459357B2 (en) 2022-10-04
CN112789287B (zh) 2024-06-21
MX2020013811A (es) 2021-03-09
EA202092819A1 (ru) 2021-05-21
JP2024109664A (ja) 2024-08-14
SI3810633T1 (sl) 2024-04-30
EP3810633B1 (fr) 2023-12-13
SG11202012747VA (en) 2021-01-28
PT3810633T (pt) 2024-02-19
LT3810633T (lt) 2024-01-10
ES2971732T3 (es) 2024-06-06
NZ771833A (en) 2024-09-27
CA3103158A1 (fr) 2020-01-02
HRP20240028T1 (hr) 2024-03-29
TW202019949A (zh) 2020-06-01
KR20210054500A (ko) 2021-05-13
AU2019294261A1 (en) 2021-02-04
BR112020026663A2 (pt) 2021-03-23
HUE065134T2 (hu) 2024-05-28
TWI851584B (zh) 2024-08-11
WO2020002325A1 (fr) 2020-01-02
EP3810633A1 (fr) 2021-04-28
FI3810633T3 (fi) 2024-02-09
CO2020016080A2 (es) 2021-01-18
EP4316504A2 (fr) 2024-02-07
MD3810633T2 (ro) 2024-05-31
MA52946B1 (fr) 2024-03-29
UA128162C2 (uk) 2024-04-24
CN118878638A (zh) 2024-11-01
US20210246169A1 (en) 2021-08-12
JP2021528449A (ja) 2021-10-21
DK3810633T3 (da) 2024-01-15
PL3810633T3 (pl) 2024-04-08
AU2019294261B2 (en) 2024-02-29
PH12020552240A1 (en) 2021-08-16
JP7488774B2 (ja) 2024-05-22
ZA202301937B (en) 2023-09-27
CN112789287A (zh) 2021-05-11
EP4316504A3 (fr) 2024-04-17
IL279620A (en) 2021-03-01
US20230012121A1 (en) 2023-01-12
RS65128B1 (sr) 2024-02-29
AU2024203362A1 (en) 2024-06-06

Similar Documents

Publication Publication Date Title
MA52948A (fr) Composés
EP3720430A4 (fr) Composés benzocarbonyle
EP3691623A4 (fr) Composés de benzosulfonyle
HUE059403T2 (hu) Vegyületek
MA52489A (fr) Nouveaux composés
EP3956033A4 (fr) Composés bicycliques
MA52560A (fr) Composés hétéroaryles tétracycliques
MA49701A (fr) Composés immunomodulateurs
MA51669A (fr) Composés
IL283692A (en) Novel composition
EP3737672A4 (fr) Composés benzamide
MA53003A (fr) Composés
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
EP4054724A4 (fr) Composés bifonctionnels
EP3853210A4 (fr) Composés antibactériens
EP3464336A4 (fr) Composés
EP4028399C0 (fr) Composés antibactériens
MA44020A (fr) Composés antitumoraux
MA50504A (fr) Composés antibactériens
MA49621A (fr) Composés bifonctionnels
MA52946A (fr) Composés
MA49522A (fr) Nouveaux composés de quinoléinone
LT3867247T (lt) Naujieji junginiai
MA53430A (fr) Nouveaux composés
DK3808747T3 (da) Imidazopyridinon-forbindelse